Index of reports
> Death (263)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vfend (Voriconazole) death. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 263 Next >>
Possible Vfend side effects in 59 year old male
Reported by a physician from United States on 2012-08-27
Patient: 59 year old male
Reactions: Drug Ineffective, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in 78 year old male
Reported by a consumer/non-health professional from United States on 2012-08-27
Patient: 78 year old male
Reactions: Aspergillosis, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in male
Reported by a physician from France on 2012-08-27
Patient: male
Reactions: Thrombotic Microangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Albumin (Human)
Indication: Product Used FOR Unknown Indication
End date: 2012-03-06
Bactrim DS
Administration route: Oral
Indication: Prophylaxis
End date: 2012-04-05
Delursan
Administration route: Oral
Indication: Cholestasis
Effexor
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-13
End date: 2012-03-22
Folic Acid
Indication: Vitamin B12 Deficiency
End date: 2012-04-05
Heparin Calcium
Indication: Prophylaxis
End date: 2012-03-21
Levothyroxine Sodium
Indication: Product Used FOR Unknown Indication
Nicardipine HCL
Administration route: Oral
Indication: Hypertension
End date: 2012-04-15
Omeprazole
Indication: Prophylaxis
Phenoxymethyl Penicillin
Administration route: Oral
Indication: Prophylaxis
End date: 2012-03-22
Plitican
Indication: Prophylaxis
Start date: 2012-03-14
End date: 2012-03-19
Sandimmune
Indication: Prophylaxis
Start date: 2012-01-23
End date: 2012-04-04
Solu-Medrol
Indication: Immunosuppression
Tiorfan
Administration route: Oral
Indication: Prophylaxis
End date: 2012-04-25
Tranxene
Administration route: Oral
Indication: Anxiety
Start date: 2012-03-13
End date: 2012-03-16
Valganciclovir
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-03-10
End date: 2012-03-16
Vfend
Indication: Prophylaxis
Zolpidem
Administration route: Oral
Indication: Insomnia
End date: 2012-03-18
Possible Vfend side effects in male
Reported by a physician from France on 2012-08-27
Patient: male
Reactions: Multi-Organ Failure, Thrombotic Microangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Albumin (Human)
End date: 2012-03-06
Clorazepate Dipotassium
Dosage: unknown dose daily
Administration route: Oral
Indication: Anxiety
Start date: 2012-03-13
End date: 2012-03-16
Delursan
Indication: Cholestasis
Effexor
Start date: 2012-03-13
End date: 2012-03-22
Folic Acid
Indication: Vitamin B12 Deficiency
End date: 2012-04-05
Heparin Calcium
Indication: Prophylaxis
End date: 2012-03-21
Levothyroxine Sodium
Indication: Hypothyroidism
Nicardipine HCL
Administration route: Oral
Indication: Hypertension
End date: 2012-04-15
Omeprazole
Indication: Prophylaxis
End date: 2012-05-11
Phenoxymethyl Penicillin
Dosage: 2 m iu daily
Administration route: Oral
Indication: Prophylaxis
End date: 2012-03-22
Plitican
Indication: Prophylaxis
Start date: 2012-03-14
End date: 2012-03-19
Sandimmune
Indication: Prophylaxis
Start date: 2012-01-23
Solu-Medrol
Indication: Immunosuppression
Sulfamethoxazole and Trimethoprim
Administration route: Oral
Indication: Prophylaxis
End date: 2012-04-05
Tiorfan
Administration route: Oral
Indication: Prophylaxis Against Diarrhoea
End date: 2012-04-25
Valganciclovir
Indication: Prophylaxis
Start date: 2012-03-10
End date: 2012-03-16
Vfend
Indication: Prophylaxis
Zolpidem
Administration route: Oral
Indication: Insomnia
End date: 2012-03-18
Other drugs received by patient: Vidaza; Cytarabine; Idarubicin HCL
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24
Patient: male
Reactions: Confusional State, Graft Versus Host Disease, RED Blood Cell Schistocytes Present, Haptoglobin Abnormal, Thrombotic Microangiopathy, Hyperuricaemia, Graft Versus Host Disease in Liver, Multi-Organ Failure, Thrombocytopenic Purpura, Thrombocytopenia, Kussmaul Respiration, Haemolysis, Haematotoxicity, Epstein-Barr Virus Infection, Renal Failure, Renal Impairment, Cytomegalovirus Infection, Nervous System Disorder, Human Herpesvirus 6 Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Albumin (Human)
Dosage: 20 g, qd
End date: 2012-03-06
Bactrim DS
Dosage: 1 df, qd
Administration route: Oral
Indication: Prophylaxis
End date: 2012-04-05
Delursan
Dosage: 1.5 g, unk
Administration route: Oral
Indication: Cholestasis
Effexor
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-22
Folic Acid
Indication: Vitamin Supplementation
End date: 2012-04-05
Heparin Calcium
Dosage: 7500 (units unknown), once daily
Indication: Prophylaxis
End date: 2012-03-21
Levothyroxine Sodium
Dosage: 150 ug, qd
Indication: Hypothyroidism
Nicardipine HCL
Dosage: 50 mg, qd
Administration route: Oral
Indication: Hypertension
End date: 2012-04-15
Omeprazole
Indication: Prophylaxis
Phenoxymethyl Penicillin
Dosage: 2 miu, qd
Administration route: Oral
Indication: Prophylaxis
End date: 2012-03-22
Plitican
Indication: Prophylaxis
Start date: 2012-03-14
End date: 2012-03-19
Sandimmune
Indication: Prophylaxis
Start date: 2012-01-23
End date: 2012-04-04
Solu-Medrol
Indication: Immunosuppression
Tiorfan
Dosage: 600 mg, qd
Administration route: Oral
Indication: Prophylaxis Against Diarrhoea
End date: 2012-04-25
Tranxene
Administration route: Oral
Indication: Anxiety
Start date: 2012-03-13
End date: 2012-03-16
Valganciclovir
Dosage: 900 mg, qd
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-03-10
End date: 2012-03-16
Vfend
Dosage: 400 ukn, qd
Indication: Prophylaxis
Zolpidem
Dosage: 10 mg, qd
Administration route: Oral
Indication: Insomnia
End date: 2012-03-18
Other drugs received by patient: Ganciclovir Sodium; Vidaza; Mycophenolate Mofetil (Cellcept)
Possible Vfend side effects in male
Reported by a physician from France on 2012-08-17
Patient: male
Reactions: Thrombotic Microangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Albumin (Human)
Indication: Product Used FOR Unknown Indication
End date: 2012-03-06
Bactrim DS
Administration route: Oral
Indication: Prophylaxis
End date: 2012-04-05
Delursan
Administration route: Oral
Indication: Cholestasis
Effexor
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-03-13
End date: 2012-03-22
Folic Acid
Indication: Vitamin B12 Deficiency
End date: 2012-04-05
Heparin Calcium
Indication: Prophylaxis
End date: 2012-03-21
Levothyroxine Sodium
Indication: Product Used FOR Unknown Indication
Nicardipine HCL
Administration route: Oral
Indication: Hypertension
End date: 2012-04-15
Omeprazole
Indication: Prophylaxis
Phenoxymethyl Penicillin
Administration route: Oral
Indication: Prophylaxis
End date: 2012-03-22
Plitican
Indication: Prophylaxis
Start date: 2012-03-14
End date: 2012-03-19
Sandimmune
Indication: Prophylaxis
Start date: 2012-01-23
End date: 2012-04-04
Solu-Medrol
Indication: Immunosuppression
Tiorfan
Administration route: Oral
Indication: Prophylaxis
End date: 2012-04-25
Tranxene
Administration route: Oral
Indication: Anxiety
Start date: 2012-03-13
End date: 2012-03-16
Valganciclovir
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-03-10
End date: 2012-03-16
Vfend
Indication: Prophylaxis
Zolpidem
Administration route: Oral
Indication: Insomnia
End date: 2012-03-18
Possible Vfend side effects in 59 year old male
Reported by a physician from United States on 2012-08-17
Patient: 59 year old male
Reactions: Leukaemia, Renal Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in 56 year old female
Reported by a physician from United States on 2012-08-14
Patient: 56 year old female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in 31 year old female
Reported by a physician from Nigeria on 2012-08-14
Patient: 31 year old female
Reactions: Fungal Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Other drugs received by patient: Itraconazole; Meropenem; Fluconazole
Possible Vfend side effects in 66 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient: 66 year old male
Reactions: Thrombotic Microangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Albumin
Dosage: form: solution
End date: 2012-03-06
Bactrim DS
Administration route: Oral
End date: 2012-03-22
Delursan
Administration route: Oral
Indication: Cholestasis
End date: 2012-05-11
Effexor
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-22
Folic Acid
Administration route: Oral
Indication: Vitamin B12 Deficiency
End date: 2012-04-05
Heparin
End date: 2012-03-21
Levothyroxine Sodium
Administration route: Oral
Indication: Hypothyroidism
End date: 2012-05-11
Nicardipine HCL
Administration route: Oral
Indication: Hypertension
End date: 2012-04-15
Omeprazole
Administration route: Oral
End date: 2012-05-11
Phenoxymethyl Penicillin
Dosage: 2 millions iu daily
End date: 2012-03-22
Plitican
Start date: 2012-03-14
End date: 2012-03-19
Sandimmune
Start date: 2012-01-23
End date: 2012-04-04
Solu-Medrol
Indication: Immunosuppression
End date: 2012-05-11
Tiorfan
Administration route: Oral
End date: 2012-04-25
Tranxene
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-16
Valganciclovir
Administration route: Oral
Start date: 2012-03-10
End date: 2012-03-16
Vfend
Dosage: powder for solution for perfusion
End date: 2012-05-11
Zolpidem Tartrate
Administration route: Oral
Indication: Insomnia
End date: 2012-03-18
Possible Vfend side effects in 66 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-10
Patient: 66 year old male
Reactions: Thrombotic Microangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Albumin (Human)
Dosage: 20 g daily
End date: 2012-03-06
Bactrim DS
Dosage: 1 df, 1x/day
Administration route: Oral
Indication: Prophylaxis
End date: 2012-04-05
Delursan
Dosage: 1.5 g daily
Administration route: Oral
Indication: Cholestasis
Effexor XR
Dosage: variable dose
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-22
Folic Acid
Dosage: 5 (unspecified unit) daily
Indication: Vitamin B12 Deficiency
End date: 2012-04-05
Heparin Calcium
Dosage: 7500 (unspecified unit) daily
Indication: Prophylaxis
End date: 2012-03-21
Levothyroxine Sodium
Dosage: 150 ug daily
Indication: Hypothyroidism
Nicardipine HCL
Dosage: 1 df daily
Administration route: Oral
Indication: Hypertension
End date: 2012-04-15
Omeprazole
Dosage: variable dose
Indication: Prophylaxis
Phenoxymethyl Penicillin
Dosage: 2 miu daily
Administration route: Oral
Indication: Prophylaxis
End date: 2012-03-22
Plitican
Dosage: variable dose
Indication: Prophylaxis
Start date: 2012-03-14
End date: 2012-03-19
Sandimmune
Dosage: variable dose
Indication: Prophylaxis
Start date: 2012-01-23
End date: 2012-04-04
Solu-Medrol
Dosage: variable dose
Indication: Immunosuppression
Tiorfan
Dosage: 600 mg daily
Administration route: Oral
Indication: Diarrhoea
End date: 2012-04-25
Tranxene
Dosage: variable dose
Administration route: Oral
Indication: Anxiety
Start date: 2012-03-13
End date: 2012-03-16
Valganciclovir
Dosage: 900 mg daily
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-03-10
End date: 2012-03-16
Vfend
Dosage: 400 (unspecified unit) daily
Indication: Prophylaxis
Zolpidem Tartrate
Dosage: 1 dosage form (df) daily
Administration route: Oral
Indication: Insomnia
End date: 2012-03-18
Possible Vfend side effects in 74 year old female
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient: 74 year old female, weighing 53.5 kg (117.7 pounds)
Reactions: Renal Failure, Organ Failure, Full Blood Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Other drugs received by patient: Morphine
Possible Vfend side effects in 31 year old female
Reported by a physician from Nigeria on 2012-08-10
Patient: 31 year old female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in 66 year old male
Reported by a physician from France on 2012-08-10
Patient: 66 year old male
Reactions: Multi-Organ Failure, Thrombotic Microangiopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Albumin (Human)
End date: 2012-03-06
Clorazepate Dipotassium
Dosage: unknown dose daily
Administration route: Oral
Indication: Anxiety
Start date: 2012-03-13
End date: 2012-03-16
Effexor
Start date: 2012-03-13
End date: 2012-03-22
Folic Acid
Indication: Vitamin B12 Deficiency
End date: 2012-04-05
Heparin Calcium
Indication: Prophylaxis
End date: 2012-03-21
Levothyroxine Sodium
Indication: Hypothyroidism
Nicardipine HCL
Administration route: Oral
Indication: Hypertension
End date: 2012-04-15
Omeprazole
Indication: Prophylaxis
Phenoxymethyl Penicillin
Dosage: 2 m iu daily
Administration route: Oral
Indication: Prophylaxis
End date: 2012-03-22
Plitican
Indication: Prophylaxis
Start date: 2012-03-14
End date: 2012-03-19
Sandimmune
Indication: Prophylaxis
Start date: 2012-01-23
Solu-Medrol
Indication: Immunosuppression
Sulfamethoxazole and Trimethoprim
Administration route: Oral
Indication: Prophylaxis
End date: 2012-04-05
Tiorfan
Administration route: Oral
Indication: Prophylaxis Against Diarrhoea
End date: 2012-04-25
Ursodiol
Administration route: Oral
Indication: Cholestasis
Valganciclovir
Indication: Prophylaxis
Start date: 2012-03-10
End date: 2012-03-16
Vfend
Indication: Prophylaxis
Zolpidem Tartrate
Administration route: Oral
Indication: Insomnia
End date: 2012-03-18
Other drugs received by patient: Idarubicin HCL; Vidaza; Cytarabine
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-10
Patient: male
Reactions: Confusional State, Graft Versus Host Disease, RED Blood Cell Schistocytes Present, Haptoglobin Abnormal, Thrombotic Microangiopathy, Hyperuricaemia, Multi-Organ Failure, Thrombocytopenic Purpura, Thrombocytopenia, Kussmaul Respiration, Haematotoxicity, Haemolysis, Renal Impairment, Renal Failure, Cytomegalovirus Infection, Nervous System Disorder, Human Herpesvirus 6 Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Albumin (Human)
Dosage: 20 g, qd
End date: 2012-03-06
Bactrim DS
Dosage: 1 df, qd
Administration route: Oral
Indication: Prophylaxis
End date: 2012-04-05
Delursan
Dosage: 1.5 g, unk
Administration route: Oral
Indication: Cholestasis
Effexor
Dosage: unk
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-22
Folic Acid
Dosage: unk
Indication: Vitamin Supplementation
End date: 2012-04-05
Heparin Calcium
Dosage: 7500 (units unknown), once daily
Indication: Prophylaxis
End date: 2012-03-21
Levothyroxine Sodium
Dosage: 150 ug, qd
Indication: Hypothyroidism
Nicardipine HCL
Dosage: 50 mg, qd
Administration route: Oral
Indication: Hypertension
End date: 2012-04-15
Omeprazole
Dosage: unk
Indication: Prophylaxis
Phenoxymethyl Penicillin
Dosage: 2 miu, qd
Administration route: Oral
Indication: Prophylaxis
End date: 2012-03-22
Plitican
Dosage: unk
Indication: Prophylaxis
Start date: 2012-03-14
End date: 2012-03-19
Sandimmune
Indication: Prophylaxis
Start date: 2012-01-23
End date: 2012-04-04
Solu-Medrol
Dosage: unk
Indication: Immunosuppression
Tiorfan
Dosage: 600 mg, qd
Administration route: Oral
Indication: Prophylaxis Against Diarrhoea
End date: 2012-04-25
Tranxene
Dosage: unk
Administration route: Oral
Indication: Anxiety
Start date: 2012-03-13
End date: 2012-03-16
Valganciclovir
Dosage: 900 mg, qd
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-03-10
End date: 2012-03-16
Vfend
Dosage: 400 unk, qd
Indication: Prophylaxis
Zolpidem Tartrate
Dosage: 10 mg, qd
Administration route: Oral
Indication: Insomnia
End date: 2012-03-18
Other drugs received by patient: Ganciclovir Sodium; Cellcept; Vidaza
Possible Vfend side effects in 74 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-09
Patient: 74 year old female
Reactions: Myocardial Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in 44 year old female
Reported by a physician from South Africa on 2012-08-06
Patient: 44 year old female
Reactions: Renal Impairment, Myelodysplastic Syndrome, Deafness
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Dosage: unk
Indication: Candidiasis
Vfend
Indication: Aspergillosis
Possible Vfend side effects in 58 year old male
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: 58 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in 63 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient: 63 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in male
Reported by a physician from Austria on 2012-08-02
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in female
Reported by a physician from France on 2012-08-02
Patient: female, weighing 75.0 kg (165.0 pounds)
Reactions: Hepatitis Acute, Lobar Pneumonia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Atovaquone
Dosage: 1.5 gram
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-03-15
End date: 2012-07-17
Revlimid
Administration route: Oral
Start date: 2012-04-13
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-17
Vfend
Dosage: 400 milligram
Administration route: Oral
Indication: Prophylaxis
Start date: 2012-03-06
End date: 2012-07-17
Other drugs received by patient: RED Blood Cells; Dexamethasone
Possible Vfend side effects in female
Reported by a physician from United States on 2012-07-31
Patient: female
Reactions: Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
Indication: Aspergillosis
Start date: 2012-04-04
Vfend
Dosage: 200 mg, 2x/day
Administration route: Oral
Possible Vfend side effects in female
Reported by a physician from United States on 2012-07-27
Patient: female
Reactions: Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Dosage: unk
Administration route: Oral
Indication: Lung Infection
Start date: 2011-09-29
End date: 2012-03-27
Vfend
Indication: Fungal Infection
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27
Patient: male
Reactions: Chronic Obstructive Pulmonary Disease
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Dosage: 1-200 mg, twice daily
Indication: Aspergillosis
Start date: 2012-04-05
Vfend
Indication: Bronchopulmonary Aspergillosis
Possible Vfend side effects in female
Reported by a physician from France on 2012-07-27
Patient: female
Reactions: Face Oedema, Oedema Peripheral, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Bactrim
Dosage: 1unit three times per week
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin HCL
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-04
Clavulanate Potassium
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Gentamicin
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Neoral
Dosage: 100mg twice per day
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Vancomycin
Dosage: 1g twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Vfend
Dosage: 200mg twice per day
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Atgam; Colistine; Neupogen
Possible Vfend side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-26
Patient: female
Reactions: Cholecystitis Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in male
Reported by a consumer/non-health professional from United States on 2012-07-26
Patient: male
Reactions: Necrotising Fasciitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: male
Reactions: Squamous Cell Carcinoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Possible Vfend side effects in male
Reported by a physician from United States on 2012-07-24
Patient: male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Vfend
Page 1 Next >>
|